59 results
8-K
CERE
Cerevel Therapeutics Holdings Inc
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
vulnerability to natural disasters, global economic factors and other unexpected events, including health epidemics or pandemics like the COVID-19 pandemic
424B5
CERE
Cerevel Therapeutics Holdings Inc
12 Oct 23
Prospectus supplement for primary offering
4:16pm
of the 2027 Notes, to the extent required;
the effect of the ongoing COVID-19 pandemic, or any other health epidemic, including as a result … and uncertainties may in the future be amplified by the ongoing COVID-19 pandemic, including as a result of the emergence of new variants
424B5
6okt xs16knr2vz4lnk
11 Oct 23
Prospectus supplement for primary offering
4:08pm
424B5
xnvr2 7d1kl
12 Aug 22
Prospectus supplement for primary offering
4:58pm
424B5
pyhwi8ah4pf
10 Aug 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
2oc osq2vyscz
10 May 22
Cerevel Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
6:35am
POS AM
m6zo1pz
10 Nov 21
Prospectus update (post-effective amendment)
7:30am
S-3
ej6 tymox1u9knzp
10 Nov 21
Shelf registration
7:27am